Table 3.
Bleeding and thromboembolic complications
| Complications (n) | NG110 | NG120 | NG130 | WG | p |
|---|---|---|---|---|---|
| Thromboembolic complications (n) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Stroke/TIAs | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| DVT | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| PE | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Bleeding complications (n) | 1 (2%) | 1 (2%) | 2 (4%) | 2 (5%) | 0.849 |
| Major bleeding | 0 (0) | 0 (0) | 1 (2%) | 0 (0) | 1.000 |
| Cardiac tamponade | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Delayed cardiac tamponade | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Retroperitoneal hemorrhage | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Hemoglobin drop ≥ 4 g/dL | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Blood transfusion required | 0 (0) | 0 (0) | 1 (2%) | 0 (0) | 1.000 |
| Minor bleeding | 1 (2%) | 1 (2%) | 1 (2%) | 2 (5%) | 0.812 |
| Pericardial effusion | 0 (0) | 0 (0) | 0 (0) | 1 (2.5%) | 0.203 |
| Inguinal hematoma | 1 (2%) | 1 (2%) | 1 (2%) | 1 (2.5%) | 1.000 |
| Hematuria | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Bleeding/thromboembolic complications | 1 (2%) | 1 (2%) | 2 (4%) | 2 (5%) | 0.849 |
TIAs transient ischemic attacks, DVT deep venous thrombosis, PE pulmonary embolism